To see the other types of publications on this topic, follow the link: Rheumatiod Arthritis.
Dissertations / Theses on the topic 'Rheumatiod Arthritis'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Rheumatiod Arthritis.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
1
Das, Avishek. "Frequency and distribution of TLR genes in some human populations of North Bengal and their association with rheumatoid arthritis." Thesis, University of North Bengal, 2018. http://ir.nbu.ac.in/handle/123456789/2827.
Full text
2
Grundy, Gillian. "A study of sexual relationships and sexual function in people with rheumatiod arthritis and partners of people with RA." Thesis, University of Central Lancashire, 2008. http://clok.uclan.ac.uk/20079/.
Full textAbstract:
Rheumatoid arthritis is a chronic inflammatory joint disease that impacts on all aspects of peoples' lives, including their sexual relationship. Healthcare professionals appear reluctant to address this area of patient care. The lack of evidenced based research to identilS' key issues and barriers may be a contributing factor to this reluctance. This project aimed to explore ways in which RA affects the sexual relationships and sexual function of patients and partners of people with RA, and to investigated levels of and barriers to communication between couples and with healthcare professionals. A mixed method approach was adopted comprising of semi-structured interviews and validated questionnaires. Semi structured interviews were used to collect detailed participant led data and questionnaires were used to collect demographic and relationship data, disability was assessed in the patient group. M interpretative phenomenological approach (IPA) was used to analyse the qualitative data with the aid of ATLAS-ti while questionnaire data was analysed using descriptive statistics (SPSS). For the majority of participants, RA had a negative impact on their sexual relationships. Five superordinate themes emerged from analysis and synthesis of the data sets. 1. Getting to know a changing body. 2. Am I still attractive? 3. It's not the be all and end all. 4. No longer swinging from the chandeliers. 5. Learning new ways of living and loving. The meaning of these superordinate themes was developed thrther through the creation of the ASBLA model. Adjustment was central to 'Getting to know a changing body', self-image was explored through 'Am I still attractive', maintaining balance was essential to 'It's not the be all and end all. Limitation was the main element of 'No longer swinging from the chandeliers' while 'Learning new ways of living and loving required acceptance. Four key factors were identified as having the potential to mediate the effects of RA on sexual relationships, knowledge, understanding, communication and commitment. Communication between patients, partners and healthcare professionals was limited. Reasons for ineffective dialogue varied.
3
Riding, S. Barbara. "The arthritic pain experience of children with juvenile rheumatoid arthritis." Thesis, University of British Columbia, 1988. http://hdl.handle.net/2429/27731.
Full textAbstract:
This study was designed to investigate the experience of having arthritic pain from the children's perspective. Previous research on how Canadian children perceive and manage arthritic pain and how it affects their daily lives is nonexistent. Therefore the purpose of this qualitative descriptive study was to explore and describe the arthritic pain experience of school age children with juvenile rheumatoid arthritis (JRA) and to understand the impact/influence of various factors on the construction of that experience.
Ten children, aged 10 to 13 years, with either early (at 2 to 4 years) or late (at 7 to 11 years) onset arthritis participated in this study. Descriptive data were obtained during two open-ended in depth interviews with the children in their homes. Using content analysis, data were analyzed for themes and their elements. An analytical framework of themes and their elements was developed that reflected the children's descriptions of and explanations for arthritic pain in the context of their day to day in the context of their day to day living with arthritis, both in the past and currently.
The children perceived pain to be synonymous with arthritis and the mediating factor in how they functioned. They described arthritic pain in relation to distinguishing factors: intensity, duration, and frequency. Intermittent arthritic pain was attributed to cessation of medications, arthritis "flare-ups," inactivity, and activity. A current concern for most children was pain attributed to activity because it meant limitations in activities with peers. The children identified strategies they used to manage pain and cope with pain's unpredictability.
The findings of this study were discussed in relation to selected research studies that either supported or refuted the findings of this study. Implications for nursing practice and research were addressed.Applied Science, Faculty of
Nursing, School of
Graduate
4
Oeser, Christian. "Polymorphismen in Kandidatengenen der Apoptose als genetische Risikofaktoren für Rheumatoide Arthritis." Doctoral thesis, Universitätsbibliothek Leipzig, 2012. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-89381.
Full textAbstract:
Die Rheumatoide Arthritis (RA) ist eine chronisch-entzündliche Systemerkrankung des Bindegewebes mit autoimmunem Charakter. In dieser Studie wurden 7 Kandidatengene, welche in zentrale Abläufe der Apoptose involviert sind (CFLAR, XIAP, NFKB1, RELA, BCL2L1, FAS, FASLG), selektiert. Innerhalb dieser Gene wurden 23 Einzel-Basen-Polymorphismen (single nucleotide polymorphisms bzw. SNPs) sowie ein Insertions-Deletions-Polymorphismus in 300 französich-kaukasischen Individuen (100 RA-Trio-Familien) mittels Einzelbasenverlängerung (Single Base Extension bzw. SBE) in einer massenspektrometrischen Analyse durch MALDI-TOF-MS (Matrix Assisted Laser Desorption/Ionization–Time Of Flight Mass Spectrometry) genotypisiert. Die Auswahl der zu untersuchenden genetischen Polymorphismen erfolgte dabei unter Berücksichtigung einer möglichen funktionellen Bedeutung, bekannter Assoziationen mit RA oder anderer Autoimmunerkrankungen, der Lage im Gen sowie der genetischen Variabilität. Die Ergebnisse der Genotypisierung wurden genutzt um die Polymorphismen bzw. Kandidatengene mit Hilfe verschiedener statistischer Methoden auf ihre Assoziation mit RA hin zu untersuchen. Die statistischen Analysen des SNPs CFLAR-rs7583529 zeigten hierbei einen nicht signifikanten Trend, wobei das minor Allel A gehäuft in RA Patienten vorkam. Das Ergebnis des Genotypen-Tests (Lathrop) für FAS-rs1800682 belegte einen protektiven Effekt für homozygote Träger des major Allels C (Lathrop pval = 0.045). Unterstützung für die gefundenen Trends bzw. Assoziationen von CFLAR-rs7583529 und FAS-rs1800682 boten Vergleiche mit Daten genomweiter Studien (NARAC/EIRA- und WTCCC-Studie). In den Assoziationsanalysen von BCL2L1-rs3181073 zeigte sich ein protektiver Effekt des minor Allels A (TDT pval = 0.008, OR = 0.51 [0.3 – 0.9], OR pval = 0.014). Der Risikoeffekt des major Allels C spiegelte sich entsprechend im Lathroptest wider, welcher eine signifikante Anreicherung des homozygoten C/C-Genotyps in den Fällen anzeigte (Lathrop pval = 0.021). Die gefundenen Assoziationen von FAS und BCL2L1 mit RA gehen mit der Hypothese konform, dass veränderte Abläufe sowohl im intrinsischen mitochondrialen (BCL2L1) als auch im extrinsischen (FAS) Weg der Apoptose in die Ätiologie der RA involviert sind. Die Ergebnisse dieser Arbeit sollten in einer zweiten unabhängigen Kohorte repliziert werden. In Folgestudien wäre es ebenfalls interessant, weitere SNPs der Kandidatengene zu genotypisieren, um die genetische Variabilität anhand der Haplotypen genauer zu analysieren. Sollten sich die o. g. Assoziationen bestätigen, sind im Weiteren funktionelle Studien bezüglich unterschiedlicher Genexpression oder verändertem Apoptoseverhalten von Zellen oder synovialem Gewebe von großem InteresseRheumatoid arthritis (RA) is a chronic inflammatory systemic disease of the connective tissue with autoimmune character. In this study, 7 candidate genes that are known to be involved in key processes of apoptosis (CFLAR, XIAP, NFKB1, REAL, Bcl2l1, FAS, FASLG) were selected. Within these genes, 23 single nucleotide polymorphisms (SNPs) and one insertion/deletion polymorphism were genotyped in a sample of 300 French Caucasian individuals (100 RA trio families) by means of Single Base Extension (SBE) and MALDI-TOF (Matrix Assisted Laser Desorption /Ionization–Time Of Flight) mass spectrometry analysis. The possible functional significance, known associations with RA or other autoimmune diseases, the location in the gene and genetic variability were taken into account during the selection of genetic polymorphisms. The SNP genotyping results were used to analyse associations of polymorphisms or candidate genes with RA by applying various statistical methods. Analysis of the SNP CFLAR-rs7583529 showed a non-significant trend toward increased frequency of the minor allele A in RA patients. The genotypic test (Lathrop) of FAS-rs1800682 revealed a protective effect for homozygous carriers of major allele C (Lathrop pval = 0.045). Data of genome-wide studies (NARAC/EIRA- and WTCCC study) provided further support for association of CFLAR-rs7583529 and FAS-rs1800682 like confirmed in this study. Association analysis of Bcl2l1-rs3181073 showed a protective effect of the minor allele A (TDT pval = 0.008, OR = 0.51 [0.3 - 0.9], pval OR = 0.014). The genotypic Lathrop-test in turn revealed a corresponding risk effect for homozygous C/C genotype carriers (Lathrop pval = 0.021). Within this study, associations of the apoptosis genes FAS and Bcl2l1 with RA were found out. These results further indicate that changes of the intrinsic mitochondrial (Bcl2l1) and extrinsic (FAS) apoptosis pathway are possibly involved in the etiology of RA. For confirmation, results of this study should be replicated in a larger independent cohort. It would also be of interest to analyze the genetic variability based on specific haplotypes of additional SNPs within candidate genes. If the aforementioned associations are confirmed, functional studies with regard to different gene expression or changed apoptosis initiation in cells or synovial tissue would be of interest
5
Kriegsmann, Mark. "MALDI MS Imaging zur Untersuchung von synovialem Gewebe." Doctoral thesis, Universitätsbibliothek Leipzig, 2013. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-118897.
Full text
6
Vingsbo, Lundberg Carina. "Chronic autoimmune arthritis in rats pathogenesis and genetic factors /." Lund : Lund University, 1997. http://catalog.hathitrust.org/api/volumes/oclc/68945081.html.
Full text
7
Ulfgren, Ann-Kristin. "Cytokines in rheumatoid arthritis /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-3823-7/.
Full text
8
DeLaura, Angela. "Rheumatoid arthritis : an overview /." Online version of thesis, 1989. http://hdl.handle.net/1850/11502.
Full text
9
Thomson, W. "Immunogenetics of rheumatoid arthritis." Thesis, University of Manchester, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383908.
Full text
10
Kalla, Asgar Ali. "Osteoporosis in rheumatoid arthritis." Master's thesis, University of Cape Town, 1989. http://hdl.handle.net/11427/26297.
Full textAbstract:
The literature is replete with reports of osteoporosis in rheumatoid arthritis, but the mechanism of bone loss remains obscure. This is probably due to the overlap with bone loss of aging and the menopause, whose exact mechanisms are also poorly understood. Against this background, a study was designed to evaluate generalised bone loss in young, premenopausal (if female), patients with rheumatoid arthritis. The protocol was designed to record demographic data, as well as information pertaining to the disease. Cortical bone mass was measured at the metacarpals and left femur, using an automated, computer-controlled technique. Trabecular bone was evaluated at the left femur (Singh index) as well as at the 3rd lumbar vertebra (Saville index). Bone kinetics were studied by the measurement of urinary excretion of calcium, phosphate and hydroxy-praline (resorption) and serum alkaline phosphatase (formation). Disease activity was measured clinically and with laboratory indices. Physical activity was indirectly measured by quantitating the disability, using the Keitel function test as well as a modified health assessment questionnaire (HAQ). The radiograph of the right wrist was scored by the Larsen index. The carpometacarpal ratio was also calculated from the radiograph. Numerous statistical techniques were applied in the analysis of the data. Healthy volunteers were used as controls. Patients with SLE were also studied, in order to compare the 2 inflammatory diseases. Patients with RA had generalised cortical bone loss (metacarpal and femur) (p < 0.001). Trabecular bone measurements were not significantly different from normals, using the crude radiographic techniques. Duration of disease was the most important clinical determinant of this bone loss. The relative contributions of disease activity and lack of physical activity to the loss of bone could not be adequately separated using conventional statistical techniques. Corticosteroid therapy did not promote metacarpal bone loss in these subjects, but may have contributed to thinning of the femoral cortex. Nonsteroidal anti-inflammatory drugs and disease modifying agents did not seem to influence the extent of the bone loss. Nutritional status and skinfold thickness did not correlate with bone mass. Dietary factors played no role in the genesis of bone loss, but may have had some effect on disease activity. Metacarpal measurements showed a sensitivity of 80% and specificity of 85% in discriminating between osteopaenic and normopaenic groups with RA. Osteopaenia could not be adequately predicted in the absence of metacarpal measurements. Metacarpal bone loss in RA was due to endosteal resorption, while in SLE it was due to periosteal resorption. The semi-automatic technique for measurement of metacarpal bone mass showed good reproducibility among 5 observers and at 2 different centres. The pathogenesis of bone loss in RA was multifactorial, the largest contribution probably coming from a humoral factor in the circulation, closely related to disease activity. Ionised calcium was elevated in 55% of RA patients, but only 5% of SLE patients. Serum PTH levels were normal in 99% of the RA subjects. Elevations in alkaline phosphatase. (25%) probably reflected disease activity rather than increased bone formation. Factor analysis of 27 variables showed that disease activity was central to the development of OP in RA. CS therapy tended to be used in the presence of active disease. Disability was not an important determinant of bone loss in RA, but may be a useful measure of activity of the disease. This study did not evaluate the relationships with sex hormonal status or vitamin D metabolism. Future research should aim at cohort analysis at 2 different periods, in order to improve our understanding of the pathogenesis of bone loss in RA.
11
Toms, Tracey. "Dyslipidaemia in rheumatoid arthritis." Thesis, University of Manchester, 2012. https://www.research.manchester.ac.uk/portal/en/theses/dyslipidaemia-in-rheumatoid-arthritis(e7808bd7-52e6-40a0-84cb-e4aadbf7505c).html.
Full textAbstract:
Introduction: Rheumatoid arthritis (RA) is known to be associated with an increased risk of cardiovascular disease (CVD), resulting in excess mortality. Dyslipidaemia has been identified as a major CVD risk factor in the general population. Current evidence would suggest that lipid metabolism is altered in RA due to inflammation, and that use of anti-inflammatory therapy may reverse some of these changes. However, the impact of such lipid changes on CVD in RA remains unknown. Data regarding the effects of RA/drug therapy on lipid structure and function are sparse. Genetic factors are important in the pathogenesis of RA and play a central role in the regulation of lipid metabolism. To date, no studies have assessed the impact of genetic polymorphisms on lipids in RA.The aim of this thesis is to: 1) assess the prevalence of dyslipidaemia in RA and the CVD risk this confers 2) establish the effects of inflammation on lipid levels and lipid ratios 3) assess the impact of anti-inflammatory drug therapy (anti-TNF, rituximab and intravenous glucocorticoids) on lipid levels, structure and function 4) assess the prevalence and associations of particular genetic polymorphisms (RA susceptibility and lipid metabolism regulating genes) with lipids in RA.Methods: Data from 400 RA patients were used to address aims 1, 2 and 4 in cross-sectional studies. All patients had a clinical assessment and fasting blood taken. Blood was processed to provide data on the lipid profile, ESR, CRP and DNA was extracted for genotyping. Aim 2 and 4 also utilised a retrospective longitudinal cohort of 550 RA patients and the DNA from 400 healthy controls, respectively. Aim 3 was addressed using a longitudinal cohort including: patients due to commence anti-TNF (n=35), rituximab (n=10), intravenous glucocorticoids (n=12); 15 RA controls on stable therapy; and 40 healthy controls. Assessments and blood samples were taken at baseline, 2 weeks and 3 months. Results: Dyslipidaemia was highly prevalent (56.8%), but undertreated in many RA patients at risk of developing CVD. Systemic inflammation associated with many of the changes in lipid levels and structure. Lipid ratios were found to be less susceptible to fluctuations due to inflammation. The use of anti-inflammatory drug therapy produced changes in lipid structure and function through both generic suppression of inflammation and drug specific mechanisms (particularly in the case of glucocorticoids). The prevalence of cholesterol ester transfer protein (CETP) and Apolipoprotein C3 genetic polymorphisms differed between RA patients and local population controls. RA susceptibility genes (HLA-DRB1-SE and TRAF1C5) and several ’lipid metabolism genes’ (Apolipoprotein E, ATP-binding cassette transporter 1 (ABCA1) and CETP) were found to associate with lipid levels within the RA population. Conclusion: Dyslipidaemia is highly prevalent in RA and currently undertreated. Dyslipidaemia in RA is regulated by numerous factors including inflammation, drug therapy and genetic factors. Further longitudinal studies are required to assess whether these findings have an impact on hard CVD endpoints.
12
Lundström, Emeli. "Genetic studies of the HLA locus in rheumatic diseases." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-852-5/.
Full text
13
Hatch, Lashley. "Statistical Information Included in Labeling for Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis." The University of Arizona, 2012. http://hdl.handle.net/10150/623641.
Full textAbstract:
Class of 2012Specific Aims: To evaluate the presence of statistical information from clinical studies in official product labeling specific for disease-modifying anti-rheumatic drugs (DMARDs) used in the treatment of rheumatoid arthritis. Methods: Data were abstracted from official product labeling DMARDs with FDA approval for treatment of rheumatoid arthritis. Each document was examined for the presence of statement regarding a priori type 1 error rate, p-values, and measures of variance. Medications were classified as either biologic or non-biologic. Main Results: A total of 14 DMARDs, 7 biologics (50%) and 7 non-biologics (50%), were found to be FDA approved for the treatment of rheumatoid arthritis. Primary outcomes consisted of American College of Rheumatology (ACR) response rates, radiographic changes, and health assessment questionnaire score (HAQ). Any measure of variance and the presence of a p-value were both found in six (43%) of the drug labels. Inclusion of p- values was found to be significantly greater in biologics compared to non-biologics for both ACR and radiographic results. Inclusion of variance was found to be significantly greater in biologics compared to non-biologics for radiographic changes only. No package inserts contained statements regarding the a priori type I error rate. Conclusions: Measures of variance are not frequently included in product labeling for either biologic or non-biologic DMARDs. However, inclusion of variance and p-values for ACR response rates and radiographic changes were more likely to be reported for biologics therapies as compared to non-biologics. A statement regarding Type 1 error rates were absent from labels regardless of outcome assessed.
14
Hatch, Lashley, and Daniel C. Malone. "Statistical Information Included in Labeling for Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis." The University of Arizona, 2012. http://hdl.handle.net/10150/614497.
Full textAbstract:
Class of 2012 AbstractSpecific Aims: To evaluate the presence of statistical information from clinical studies in official product labeling specific for disease-modifying anti-rheumatic drugs (DMARDs) used in the treatment of rheumatoid arthritis. Methods: Data were abstracted from official product labeling DMARDs with FDA approval for treatment of rheumatoid arthritis. Each document was examined for the presence of statement regarding a priori type 1 error rate, p-values, and measures of variance. Medications were classified as either biologic or non-biologic. Main Results: A total of 14 DMARDs, 7 biologics (50%) and 7 non-biologics (50%), were found to be FDA approved for the treatment of rheumatoid arthritis. Primary outcomes consisted of American College of Rheumatology (ACR) response rates, radiographic changes, and health assessment questionnaire score (HAQ). Any measure of variance and the presence of a p-value were both found in six (43%) of the drug labels. Inclusion of p-values was found to be significantly greater in biologics compared to non-biologics for both ACR and radiographic results. Inclusion of variance was found to be significantly greater in biologics compared to non-biologics for radiographic changes only. No package inserts contained statements regarding the a priori type I error rate. Conclusions: Measures of variance are not frequently included in product labeling for either biologic or non-biologic DMARDs. However, inclusion of variance and p-values for ACR response rates and radiographic changes were more likely to be reported for biologics therapies as compared to non-biologics. A statement regarding Type 1 error rates were absent from labels regardless of outcome assessed.
15
Schatz, Annika Katrin. "Homöostatische Mechanismen der CD4+ T-Zellgenese bei Rheumatoider Arthritis." Doctoral thesis, Universitätsbibliothek Leipzig, 2016. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-215633.
Full textAbstract:
Die Rheumatoide Arthritis ist eine Autoimmunerkrankung, die mit grundlegenden Veränderungen im CD4+ T-Zellpool einhergeht. Viele Studien konnten zeigen, dass die Gruppe der T-Helferzellen bei erkrankten Personen vermehrt Anzeichen von replikativer Seneszenz und das adaptive Immunsystem deutliche Zeichen der Immunoseneszenz aufweisen. Als zum Teil ursächlich hierfür konnte ein reduzierter Thymusoutput festgestellt werden. Das Ziel der vorliegenden Studie war es, aufbauend auf Erkenntnissen von Six und Kollegen anhand einer Lymphozytenvorläuferzelle, die im peripheren Blut zirkuliert, in vivo in der Lage ist, den Thymus zu besiedeln und sich in reife T-Zellen zu entwickeln, den Thymusinput abzuschätzen, um eine defiziente Thymusbesiedlung als eventuelle Ursache des reduzierten Thymusoutput festzustellen.
Hierzu wurde das Blut von 28 Patienten mit Rheumatoider Arthritis und altersentsprechenden gesunden Kontrollen mittels Durchflusszytometrie auf mehrere relevante reife T-Helferzellpopulationen, naive CD4+ T-Zellen und benannte lymphozytäre Vorläuferzelle untersucht. Es konnten dann direkte Vergleiche des prozentualen Anteils bestimmter T-Helferzellgruppen zwischen Erkrankten und Gesunden gezogen sowie Korrelationen verschiedener Zellgruppen untereinander hergestellt werden.
Die gewonnenen Ergebnisse wurden mit der hierzu vorliegenden Literatur verglichen und diskutiert.
16
Hermann, Kay-Geert. "Die rheumatoide Arthritis." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2000. http://dx.doi.org/10.18452/14542.
Full textAbstract:
Multimedia - Wort des Jahres 1995 - taucht als populärer Begriff in allen Bereichen unserer Gesellschaft auf. Auch an Universitäten erhofft man sich durch die Einführung von computerunterstützten Lernformen eine höhere Qualität der Lehre sowie Kosteneinsparungen. Nach ersten Versuchen in den 60er Jahren war das Neue in den 90ern die realitätsnahe, multimediale Simulation von Entscheidungssituationen. Auf dem Gebiet der Rheumatologie ist derzeit jedoch noch ein Mangel an deutschsprachigen Softwaretiteln zu erkennen. Ziel war die Erstellung eines multimedialen Kompendiums über die rheumatoide Arthritis für den Einsatz in der universitären und postgraduierten Lehre. Das System soll als elektronisches Nachschlagewerk und als Basis für interaktive Diashows geeignet sein. Mit Hilfe eines Apple Macintosh und der Autorensoftware Macromedia Director wurde eine CD-ROM entwickelt, die sowohl für Macintosh- als auch für Windows-Computer geeignet ist. Die Beschreibung der Symptome der rheumatoiden Arthritis und der erforderlichen Untersuchungstechniken nimmt mit 31% der Bildschirmseiten den größten Teil des vorliegenden Multimedia-Kompendiums ein. Weitere Schwerpunkte wurden auf Pathogenese (19%), bildgebende Verfahren (14%), Differentialdiagnosen (11%), Therapie (10%) und Laboruntersuchungen (7%) gelegt. Videos und Animationen dienen der Illustration zellulärer Vorgänge und der Zusammenfassung klinischer Untersuchungstechniken. Etablierte Kriterienkataloge für elektronische Medien dienten der Qualitätssicherung im Entwicklungsprozeß. Eine parallel durchgeführte formative Evaluation lieferte erste Erkenntnisse über Praxistauglichkeit und Stabilität des Programmes, ohne jedoch eine fundierte summative Evaluation ersetzen zu können. Multimedia-Lehrbücher wie das vorliegende Kompendium stellen für den konventionellen Unterricht eine ideale Ergänzung zum klassischen Lehrbuch dar und dienen für die problemorientierte Ausbildung als schnell zur Verfügung stehende Wissensbasis. Jedoch blieben bei der fakultativen Nutzung von computerbasierten Lernmöglichkeiten in Lernzentren die Ergebnisse bisher hinter den Erwartungen zurück. Es ist zu diskutieren, inwieweit die Vorteile der Multimedia-Technologie durch gezielte Integration in das Curriculum an deutschen Hochschulen zu Kosten- und Zeitersparnissen führen können.Multimedia - word of the year 1995 in Germany - is a popular term cropping up in all areas of society. Universities, too, hope to improve the quality of teaching and to cut costs by introducing computer-based forms of learning. Following initial attempts in the sixties, a new aspect introduced in the nineties was the life-like multimedia simulation of decision-making situations. In medicine, there still is a lack of German-language software packages in rheumatology. The aim of the present project was to develop a multimedia compendium on rheumatoid arthritis for teaching at the university and postgraduate level. The system was intended to serve both as an electronic work of reference and as a basis for interactive slide presentations. Using the authoring tool Macromedia Director on an Apple Macintosh computer, a CD-ROM was developed that can be run on Macintosh and Windows computers alike. The largest part of the multimedia compendium now available (31% of the screen pages) is dedicated to the description of the symptoms of rheumatoid arthritis and examination techniques. Other main areas are pathogenesis (19%), imaging modalities (14%), differential diagnoses (11%), therapy (10%), and laboratory tests (7%). Videos and animations serve to illustrate cellular processes and to summarize the clinical examination techniques. Catalogues of established criteria for electronic media were adhered to during development to assure quality. A simultaneously performed formative evaluation yielded initial results about the practicability and stability of the program but cannot replace a thorough summative evaluation. Multimedia textbooks such as the compendium presented here are ideal supplements to classical textbooks in conventional teaching, providing a rapidly accessible knowledge base for problem-oriented training. However, the results achieved with computer-based learning tools available for optional use at teaching centers have so far lagged behind expectations. It remains to be discussed to what extent the advantages of multimedia technology can save both cost and time by being selectively integrated into the curriculum at German universities.
17
Esber, Anke. "Charakterisierung des autonomen Nervensystems in Ruhe sowie unter Stresseinwirkung bei Patienten mit Rheumatoider Arthritis." Doctoral thesis, Universitätsbibliothek Leipzig, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-154300.
Full textAbstract:
Eine Dysregulation neuro-immunologischer Interaktionen und eine veränderte Stressantwort werden als Teil der Pathogenese der Rheumatoiden Arthrtitis (RA) diskutiert. Dabei könnte eine autonome Dysfunktion eine wichtige Rolle spielen. Um dem nachzugehen, wurde an Patienten mit unterschiedlicher Krankheitsaktivität die Aktivität des autonomen Nervensystems in Ruhe und in Reaktion auf minor Stress sowie erstmals deren Assoziation zu Gen-Polymorphismen β2- adrenerger Rezeptoren (β2ARs), welche sich u.a. auf Immunzellen befinden, untersucht. Zur Bestimmung autonomer Aktivität wurde an 112 RA- und 48 Osteoarthrose-Patienten die sympathische Hautantwort (SSR) sowie die Herzratenvariabilität (HRV) getestet. Standardisierte Stresstests kamen zur Anwendung. Eine Allel-spezifische Polymerase-Ketten-Reaktion diente zur Ermittlung der Varianten des β2ARs an Aminosäureposition 16, 27 und 164. Es konnte gezeigt werden, dass die autonome Aktivität bei RA in Ruhe durch eine signifikant erhöhte Herzfrequenz, ein Überwiegen des Sympathikus im Verhältnis zum Parasympathikus sowie eine signifikant erniedrigte Parasympathikusaktivität gekennzeichnet ist. Die Stressantwort bei RA war signifikant häufiger pathologisch als bei der Kontrollgruppe und durch signifikante Hypoaktivität und Hyporeaktivität des Parasympathikus sowie eine signifikant erniedrigte HRV charakterisiert. Das Zusammenspiel beider Schenkel des ANS erschien gestört. Die SSR-Werte befanden sich im Normbereich. Schlechtere Werte waren jedoch signifikant mit hohem CRP assoziiert. Desweiteren war Heterozygotie an allen Gen-Positionen der β2ARs signifikant mit RA assoziiert. Gln27Gln (signifikant häufiger für Gesunde) ging mit signifikant niedrigerer Krankheitsaktivität einher. Starkes Überwiegen des SNS in Ruhe sowie niedrige parasympathische Aktivität (HRV-Daten) waren signifikant mit hoher Krankheitsaktivität assoziiert. Zusammenfassend weist die vorliegende Arbeit auf eine autonome Dysregulation bei Patienten mit RA hin, was mit klinischen Parametern der RA assoziiert war. Weiterhin unterstreicht die Studie die Assoziation von β2AR Polymorphismen mit einer RA und liefert einen weiteren Beitrag zum Verständnis der Pathogenese dieser Erkrankung.
18
Freimanis, Graham L. "The detection and role of human endogenous retrovirus K (HML-2) in rheumatoid arthritis." Thesis, University of Wolverhampton, 2008. http://hdl.handle.net/2436/41777.
Full textAbstract:
Human endogenous retroviruses are the remnants of ancient retroviral infections present within our genome. These molecular fossils show similarities with present day exogenous retroviruses but act as typical Mendelian elements that are passed vertically between generations. Despite being repeatedly linked to a number of autoimmune diseases and disorders, no conclusive proof has been identified. Rheumatoid arthritis (RA) is one such disease which has been associated with an increase in HERV expression, compared to controls. In order to elucidate a clear role for HERVs in RA pathogenesis, autoantigens implicated in disease pathogenesis were scanned for sequence homology to retroviral genes. Such epitopes would induce antibodies cross reactive with host proteins, resulting in disease. Short peptides mimicking these regions were synthesised and the prevalence of anti-HERV antibodies was determined in RA patients and disease controls. Additionally, a novel real-time Polymerase Chain Reaction (PCR) assay was developed to accurately quantify levels of HERV-K (HML-2) gag expression, relative to normalised levels of housekeeping gene expression. Both serological and molecular assays showed significant increases in HERV-K (HML-2) activity in RA patients compared to disease controls with CD4+ lymphocytes harbouring the highest activity. The real-time assay was also used to determine whether factors within the synovium could modulate HERVs, resulting in their upregulation. Exogenous viral protein expression and pro-inflammatory cytokines were shown to exert a significant modulatory effect over HERV-K (HML-2) transcription. From this data, it is clear that RA patients have increased levels of HERV-K (HML-2) gag activity compared to controls. Despite this it is likely that factors within the synovium such as exogenous viral expression and pro-inflammatory cytokines also influence HERV-K (HML-2) transcription possibly contributing to a role of bystander activation, i.e. being influenced by external factors, rather than actively contributing to disease processes. The exact role of HERVs in RA pathology remains elusive; however this research proposes several mechanisms by which HERV-K (HML-2) may contribute to disease.
19
Gutowska-Owsiak, Danuta. "NKT Cells in Rheumatoid Arthritis." Thesis, University of Liverpool, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.526938.
Full text
20
Eurenius, Eva. "Physical activity in rheumatoid arthritis /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-697-2/.
Full text
21
Reynolds, Sophie L. "Vascular dysfunction in rheumatoid arthritis." Thesis, Cardiff University, 2010. http://orca.cf.ac.uk/54162/.
Full textAbstract:
These findings suggest that systemic and vascular wall levels of matrix metalloproteinase-9, related to inflammation at the joint site, may play a prominent role in the development of vascular dysfunction in this experimental model. This thesis goes someway to elucidating the potential mechanisms of vascular dysfunction in rheumatoid arthritis.
22
Wright, Helen Louise. "Neutrophil Function in Rheumatoid Arthritis." Thesis, University of Liverpool, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.510936.
Full text
23
Emery, P. "Immune responses in rheumatoid arthritis." Thesis, University of Cambridge, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.598845.
Full text
24
Duke, O. L. "Immunological observations in rheumatoid arthritis." Thesis, University of Cambridge, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.598674.
Full text
25
Rantapää, Dahlqvist Solbritt. "Genetic markers in rheumatoid arthritis." Doctoral thesis, Umeå universitet, Reumatologi, 1985. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101305.
Full textAbstract:
Genetic as well as environmental factors are believed to be of importance in the etiology of rheumatoid arthritis (RA). There are a number of previous studies of genetic markers in RA, but so far no genetic linkage and only a few associations have been found. Of the associations only one (with the HLA antigen DR4) appears to be well documented. In most previous association studies the patients have not been divided according to sex and family history of RA. In this investigation the HLA antigens A, B and DR and five serum protein systems (Bf, C3, Pi, Hp and Tf) were studied in patients with erosive rheumatoid arthritis (RA), from northern Sweden. Special attention was paid to variations in the strength of associations according to sex and family history of polyarthritis. The following results were found: The frequency of the HLA antigen B27 was significantly increased in the North-Swedish population (16.6%) and among patients with a family history of polyarthritis (42.6%). In agreement with previous investigations a significantly increased frequency of the DR4 antigen was found in the RA patients. In the properdin factor B (Bf) system the S phenotype was found to be significantly increased in male patients and in patients with a family history of polyarthritis, more severe form of RA and high titres of rheumatoid factor. No significant differences with respect to phenotype or gene frequencies were found in the C3 complement system. Thus, the association between RA and C3 found in previous investigations was not confirmed. A significant increase of rare alpha-1-antitrypsin (Pi) types (MS, MZ, MF and SZ) was found among RA patients. However, the increase concerned mainly Z heterozygotes and was more strongly pronounced among male patients. In the haptoglobin system a significant increase of the Hp^ gene and the Hp2-2 type was found among patients with a family history of polyarthritis, more pronounced among males. A significant increase of the transferrin gene and of the 2 type was found among male RA patients, more pronounced among patients with a family history of polyarthritis. In 6 out of 8 gene loci studied significant associations were found, which is in agreement with a multifactorial etiology of RA. The results were largely in agreement with the hypothesis that associations would be expected to be stronger in males and in patients with a family history of polyarthritis. A notable finding was the high frequency of first degree relatives (around 40%) with symmetric peripheral polyarthritis of which more than 70% had a diagnosis of RA verified by hospital records.Diss. (sammanfattning) Umeå : Umeå universitet, 1985, härtill 6 uppsatser.
digitalisering@umu
26
Lacroix, Brigitte. "Pharmacometric Modeling in Rheumatoid Arthritis." Doctoral thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-247917.
Full textAbstract:
Biologic therapies have revolutionized the treatment of rheumatoid arthritis, a common chronic inflammatory disease, mainly characterized by the chronic inflammation of the joints. The activity and progression of the disease are highly variable, both between subjects and between the successive assessments for the same subject. Standardized assessments of clinical variables have been developed to reflect the disease activity and evaluate new therapies. Pharmacokinetics-pharmacodynamic (PKPD) models and methods for analyzing the generated time-course data are needed to improve the interpretation of the clinical trials’ outcomes, and to describe the variability between subjects, including patients characteristics, disease factors and the use of concomitant treatments that may affect the response to treatment. In addition, good simulation properties are also desirable for predicting clinical responses for various populations or for different dosing schedules. The aim of this thesis was to develop methods and models for analyzing pharmacokinetic and pharmacokinetic-pharmacodynamic (PKPD) data from rheumatoid arthritis patients, illustrated by treatment with a new anti-TNFα biologic drug under clinical development, certolizumab pegol. Two models were developed that characterized the relationship between the exposure to the drug and the efficacy ACR variables that represent improvement of the disease; a logistic-type Markov model for 20% improvement (ACR20) and a continuous-type Markov model for simultaneous analysis of 20% (ACR20), 50% (ACR50) and 70% (ACR70) improvement. Both models accounted for the within-subjects correlation in the successive clinical assessments and were able to capture the observed ACR responses over time. Simulations from these models of the ACR20 response rate supported dosing regimens of 400 mg at weeks 0, 2 and 4 to achieve a rapid onset of response to the treatment, followed by 200 mg every 2 weeks, or alternative maintenance regimen of 400 mg every 4 weeks. The immunogenicity induced by the biologic drug was characterized by a time to event model describing the time to appearance of antibodies directed against the drug. The immunogenicity was predicted to appear mainly during the first 3 months following the start of the treatment and to be reduced at higher trough concentrations of CZP, as well as with concomitant administration of MTX. The full time-course of sequential events, such as dose-exposure-efficacy relations, is most accurately described by a simultaneous analysis of all data. However, due to the complexity and runtime limitations of such an analysis, alternatives are often used. In this thesis, a method, IPPSE, was developed and compared to the reference simultaneous method and to existing alternative methods. The IPPSE method was shown to provide accuracy and precision of estimates similar to the simultaneous method, but with easier implementation and shorter run times. In conclusion, two PKPD models and one immunogenicity model were developed for evaluation of the response of a biologic drug against rheumatoid arthritis that allowed accurate analysis and simulation of clinical trial data, as well as serving as examples for how a model-informed basis for decisions about biological drugs can be created.
27
Pritchard, M. L. "Psychological aspects of rheumatoid arthritis." Thesis, University of Exeter, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.381050.
Full text
28
Martin, Rosemary H. "Dietary factors in rheumatoid arthritis." Thesis, University of Ulster, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268590.
Full text
29
Houssien, Dhiya Taj Alhaj. "Outcome studies in rheumatoid arthritis." Thesis, King's College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298543.
Full text
30
Bedwell, A. E. "Immunological abnormalities of rheumatoid arthritis." Thesis, University of Bristol, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.372005.
Full text
31
Adlan, Ahmed. "Autonomic function in rheumatoid arthritis." Thesis, University of Birmingham, 2016. http://etheses.bham.ac.uk//id/eprint/6705/.
Full textAbstract:
Rheumatoid arthritis (RA) is a chronic inflammatory condition with poorly understood pathophysiology and increased cardiovascular risk. The mechanisms for increased cardiovascular risk are not fully known, however one novel mechanism explored in this thesis is autonomic nervous system (ANS) dysfunction. The thesis comprises of: a systematic literature review; two case-control studies (n=30 RA patients, n=34 controls; a longitudinal case-study (n=1 RA patient)); a cohort study (n=112 RA patients); and a randomised placebo controlled crossover study (n=10 healthy controls). The work presented in this thesis demonstrates that ANS dysfunction is prevalent in ~60 % of RA patients and characterised by heightened sympathetic outflow to the peripheral vasculature (determined by muscle sympathetic nerve activity using microneurography), depressed baroreflex control of heart rate (determined using the modified Oxford technique), depressed heart rate variability and heightened vascular responses to stressors (cold pressor test and mental stress). Inflammation was associated with ANS dysfunction, and may well contribute to the increased cardiovascular risk seen in RA. Further studies are required to: confirm these findings; determine whether therapeutic strategies to restore ANS function improve prognosis in RA; and further explore the precise mechanisms by which inflammatory cytokines may influence ANS function in health and disease.
32
Hildalgo, Ester. "T cells in Rheumatoid Arthritis." Thesis, University of Birmingham, 2011. http://etheses.bham.ac.uk//id/eprint/1715/.
Full textAbstract:
Identification of the role of T cells and their interaction with other cell types remains a major challenge to our understanding of the pathogenesis of rheumatoid arthritis. In this study we have investigated the regulation of the response of T cells infiltrating the rheumatoid joint to IL-6. Furthermore we have investigated the level of T cell activation in the early stages of rheumatoid arthritis. Interleukin-6 is an important regulator of T cell differentiation and survival. It exerts its biological function by either directly binding to the complete IL-6 receptor consisting of CD126 CD130 or via transsignaling, when sIL6R-IL6 complexes bind to CD130. This study addresses the expression and regulation of these receptor components on the T cells infiltrating the rheumatoid joint. While compared to blood T cells, CD126 expression was found at low levels on synovial fluid and tissue T cells, expression of CD130 on synovial tissue T cells was comparable to that of blood T cells, with lower levels in synovial fluid T cells, both at protein and mRNA level. When exposed to sIL6R-IL6 complexes, tissue derived T cells responded with a higher level of STAT3 phosphorylation compared to cells incubated with IL-6, suggestive of transsignaling. High CD130 expression was demonstrable in T cells in the perivascular cuff area. Among a range of cytokines tested, IL-6 reduced CD126 and CD130 expression while IL-10, which is expressed at high levels in the perivascular infiltrate, induced expression of CD130. Taken together these data suggest that the inflammatory microenvironment maintains responsiveness to IL-6 transsignalling by cytokine driven CD130 expression on CD4 positive T cells. To address the question whether the role of T cells changes during the course of progression of RA, we analysed the expression of T cells activation markers on synovial fluid and peripheral blood T cells from patients at the very early stage of disease (within 3 months of disease onset) compared to patients with established or self resolving arthritis. Expression of CD69, CD71 and HLA-DR was upregulated on synovial fluid T cells compared to peripheral blood but there were no differences between the different groups of patients. Furthermore, we quantified the proportion of T cells expressing the invariant TCR Vα24Jα18 in synovial fluid and blood of the same groups of patients. We found a lower frequency of iNKT cells in the synovial fluid of very early arthritis patients compared to other patients. While this is a preliminary result, it suggests that there may be a role for these cells in the regulation of disease susceptibility.
33
Hutchinson, David. "Cigarette smoking and rheumatoid arthritis." Thesis, University of Leicester, 2003. http://hdl.handle.net/2381/29431.
Full textAbstract:
The principle aim of this study was to test the hypothesis that heavy smoking is an aetiological factor in RA and generates a distinct subgroup of the disease definable in terms of clinical phenotype, particularly severity. A second aim was to investigate possible molecule mechanisms linking smoking with RA and what I believe to be candidate mechanisms involving the detoxifying glutathione S transferase Mu 1 (GST M1) gene and oxidative damage to alpha 1 proteinase (alpha1 PI). These studies involved a review of the literatures regarding the link between RA and both smoking and alpha1 PI deficiency. I investigated the relationship between heavy cigarette smoking and hospital based, more severely affected RA patients. Additionally, the age of onset and smoking history was compared in familial and sporadic RA cases. Regarding smoking and severity of RA, a cohort of RA patients were studied to determine if smoking was an independent risk factor for severe RA and whether this effect was influenced by the presence (GSTM1-1) or absence (GSTM1-0) of the GST M1 gene. Oxidative damage in RA to the alpha1 PI protein was studied in relation to rheumatoid disease activity, GST M1 and cigarette smoking. The oxidative damage to alpha1 PI was measured in terms of serum levels of Immunoglobulin A-1 PI was measured in terms of serum levels of Immunoglobulin A-alpha1 PI (IgA-alpha1 PI). In summary, I have shown that heavy smoking is strongly associated with hospital based RA. Secondly, that familial RA presents at an earlier age than sporadic RA in individuals smoking at disease onset only, and that sporadic RA patients are significantly more likely to smoke at disease onset that familial RA patients. I have confirmed previous findings that raised serum IgA-alpha1 PI levels are associated with erosive as opposed to non-erosive RA cases.
34
Fang, Jierui. "Responsive wearables for rheumatoid arthritis." Thesis, Massachusetts Institute of Technology, 2020. https://hdl.handle.net/1721.1/127855.
Full textAbstract:
Thesis: S.B. in Art and Design, Massachusetts Institute of Technology, Department of Architecture, May, 2020Cataloged from PDF version of thesis.
Includes bibliographical references (pages 34-36).
The purpose of this thesis is to investigate and create more responsive and adaptive assistive technology for patients with rheumatoid arthritis (RA), using computational design methods to embed individualized data within the design and materiality. Rheumatoid arthritis is a chronic, autoimmune disease that attacks the joints and causes progressive deformity and bone erosion directed mostly at joint linings and cartilage. Living with RA means sudden flare-ups of pain and inflammation that can last anywhere from hours to months and dramatically impact the ability to accomplish ordinary tasks. While there is no cure, the disease can be slowed down through intensive drugs and or mitigated with assistive wearable devices such as braces, splints, and compressive gloves. These wearables are used to minimize swelling in affected joints, lessen ulnar deviating forces, and reduce pain. However, many people are unwilling to wear these devices because they can be quite obtrusive and hinder patients' lifestyles. Most wearables are only available in set sizes, and when sized incorrectly can aggravate pain and symptom flare-up or have no healing benefits. This thesis asks whether and how computational design methods can be applied to alleviating unique pain points faced daily by people with chronic health issues such as RA and other physical joint or musculature needs. Given that each person suffering from rheumatoid arthritis manifests the debilitating effects of the disease in different ways, this leads to the question of how more effective and personalized assistive devices can be designed using computational design methods that do not put the onus on the user to perform corrective action, but rather automatically offer responsive support as needed.
by Jierui Fang.
S.B. in Art and Design
S.B.inArtandDesign Massachusetts Institute of Technology, Department of Architecture
35
Scott, Ian Clifford. "Risk prediction in rheumatoid arthritis." Thesis, King's College London (University of London), 2014. https://kclpure.kcl.ac.uk/portal/en/theses/risk-prediction-in-rheumatoid-arthritis(e69fd700-7819-41d6-96ae-dc26e1896e1a).html.
Full textAbstract:
As rheumatoid arthritis (RA) is a heterogeneous disease whose course and treatment response varies between patients, a stratified approach to its management is required. This thesis aimed to facilitate the risk prediction that underpins stratified medicine in RA. Its primary aim was to improve the knowledge of which clinical and genetic factors predict RA’s onset, disease course and treatment responses. Its secondary aim was to develop a prediction modelling framework that harnessed these factors to inform clinical care. There were five key findings. Firstly, it demonstrated a significant inverse association between alcohol consumption and RA development when the evidence across published studies was pooled using meta-analytical techniques. This suggests alcohol may protect against RA. Secondly, it demonstrated that only HLA RA susceptibility variants associated with radiological progression in a clinical trial cohort of early, active RA patients. This suggests the non-HLA genetic architectures of RA susceptibility and severity may, at least partially, differ. Thirdly, it provided evidence that anti-citrullinated protein antibodies (ACPA) can identify patients with early, active RA that are most likely to benefit from combination treatments. Fourthly, it demonstrated that estimating an asymptomatic individual’s risk of RA is possible, through developing and validating a risk prediction model that uses computer simulation to improve upon the discriminative abilities of existing RA prediction models. Finally, it highlighted the importance of considering RA’s heterogeneity when assessing its predictive factors; alcohol’s likely protective effect was predominantly seen in ACPA-positive disease and genetic and environmental factors had different impacts on the risk of developing younger and older onset RA. In conclusion this thesis has contributed to stratified medicine in RA by better characterising which predictive factors are relevant to its development, severity, treatment needs and responses and developing a risk prediction modelling framework that may be applicable to many aspects of stratified care.
36
MacKay, Kirsten Robyn. "Genetic susceptibility to rheumatoid arthritis." Thesis, University of Bath, 2003. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.288240.
Full textAbstract:
The heritability of Rheumatoid Arthritis is approximately 60%. Although association with the HLA region is well recognised, these genes account for only 40% of the total genetic contribution. Linkage mapping and association studies need to proceed in parallel to identify which non-MHC genes are involved in the remaining 60% of the genetic contribution. The work described in this thesis represents a systematic approach to identifying these non-HLA effects, using genome-wide linkage mapping and candidate gene methods. To identify regions exhibiting genetic linkage to rheumatoid arthritis a systematic, whole genome linkage analysis was undertaken. Two hundred and fifty-one affected sibling pairs from 182 United Kingdom families were studied using 365 highly informative microsatellite markers. Highly significant linkage was identified around the HLA region on chromosome 6 (max LOD = 4.8 at 44.9cM, p=0.000001). Eighteen other sites of nominal linkage (p < 0.05) were identified on chromosomes 1, 2, 3, 4, 6, 7, 10, 12, 14, 16, 21 and the X chromosome by single point analysis (23 markers). Eight of the non-MHC regions (on chromosomes 1, 6, 7, 14, 16, 21, and X) also showed evidence of linkage by multi-point analysis. A parallel linkage study designed to replicate the 25 regions of nominal linkage (p < 0.05) reported following a genome-wide linkage study of 97 European affected sibling pair families was also undertaken. Fifty-nine microsatellites within the 25 regions of interest (including IDDM6 on chromosome 18 and IDDM9 on chromosome 3) were used to genotype 368 affected sibling pairs from 280 families. Markers on chromosomes 12, 15, and 21 (d12s95, CYP 19, d21s1252) showed evidence of nominal linkage with p values ≤ 0.05. Markers close to IDDM 6 on chromosome 18 showed p values of between 0.1 and 0.5, not lending additional support to a locus near IDDM6 in RA. Interleukin 10 (IL10), an immunoregulatory cytokine, is a potent up-regulator of B cell production and differentiation but has anti-inflammatory capabilities and can directly down-regulate TNF, IL1, IL8 and IFNy production. Data from twin and family studies suggest large inter-individual variations in secretion which are 75% heritable and as such IL10 is a plausible candidate gene for involvement in RA. It is highly polymorphic with point mutations in the promoter region and two microsatellite loci IL10.R and IL10.G, 1.1 and 4kb upstream of the transcription initiation site. Higher levels of IL10 secretion have been associated with allele 2 of IL10.R (IL10.R2) and IL10.R3 has been associated with decreased secretion. Additionally, a case-control study including two independent Caucasian populations and one African-American cohort found an over-representation of the IL10.R2 allele with a concomitant reduction of IL10.R3 in all three rheumatoid arthritis populations. Three studies investigating IL10 were undertaken. Two case-control studies including two cohorts of racially distinct RA patients (186 UK Caucasians with severe rheumatoid arthritis and 138 South Africans of Zulu or Sotho origin) were performed. An association with RA was not confirmed in either study but demonstrated significantly different frequencies of the IL10.R2 allele in the two study populations. The third study was a family-based association study and included 163 probands and their families. Single marker and haplotypic association analysis was performed by transmission disequilibrium testing (TDT analysis) using the software package TRANSMIT. The IL10.R1 allele was transmitted to affected individuals more frequently than expected (p < 0.05) and the IL10.R3 allele was transmitted less frequently than expected (p < 0.05). This effect was particularly pronounced with the IL10.R3/IL10.G10 haplotype (p < 0.005). The still stronger negative association identified with the IL10.R3/IL10.G10 haplotype suggested it was not IL10.R itself but another polymorphism on the particular haplotype that may be primarily involved with RA. The application of these methods to the examination of the genetic component of RA is discussed. Plans for future work include systematic genome-wide screening of positional candidates and evaluation of candidates from studies of other human and animal models of inflammatory disease.
37
Iaquinta, Monica L. "The phenomenological lived experience of rheumatoid arthritis." Morgantown, W. Va. : [West Virginia University Libraries], 2001. http://etd.wvu.edu/templates/showETD.cfm?recnum=1842.
Full text
38
Spooner, Luke. "Preventing rheumatoid arthritis : understanding factors that influence decisions to take preventative treatments for rheumatoid arthritis." Thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/62681.
Full text
39
Chan, Vivien. "Use of leflunomide in rheumatoid arthritis /." [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18573.pdf.
Full text
40
Bishop, Carole Marie. "Coping with pain in rheumatoid arthritis." Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29207.
Full textAbstract:
This research investigated the role of coping strategies in reducing the pain experience of rheumatoid arthritis (RA) patients over a seven-day period. Sixty-three patients completed a twice-daily structured dairy consisting of an eight scale revision of the Ways of Coping (WOC), the depression subscale of the Affects Balance Scale (ABS), and a pain visual analogue scale (VAS). Multivariate analyses for repeated measures identified two coping strategies, Self-Care and Positive Reappraisal, as significantly effective in pain reduction. Self-Care includes behavioral attempts to manage the symptoms of RA. Positive Reappraisal involves cognitive efforts to redefine pain experience in positive terms. The other six coping strategies also demonstrated a trend to increased use on days when pain decreased. These data imply that intraindividual approaches in examining the coping/pain association have potential benefit for determining a causal relation between coping and pain.Medicine, Faculty of
Cellular and Physiological Sciences, Department of
Graduate
41
Harney, SineÌad M. J. "Major histocompatability genetics of rheumatoid arthritis." Thesis, University of Oxford, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.419294.
Full text
42
Saravanan, Vadivelu. "Small Airway Obstruction in Rheumatoid Arthritis." Thesis, University of Newcastle Upon Tyne, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.519460.
Full text
43
Mewar, Devesh. "Studies on autoantigens in rheumatoid arthritis." Thesis, University of Sheffield, 2003. http://etheses.whiterose.ac.uk/3455/.
Full textAbstract:
This thesis describes the use of phage display for the isolation of autoantigens in rheumatoid arthritis. The potential of the technology is demonstrated by the isolation of an autoantigen, eukaryotic translation elongation factor 1a1 (eEF 1 (x 1)) from a fibroblast cDNA library using rounds of selective enrichment with IgG from RA patients. Subsequently in order to isolate joint-specific antigens a phage-displayed cDNA library from rheumatoid pannus was generated and screened with analogous procedures. From the clones isolated, putative candidate autoantigens were identified. The presence of anti- eEF 1a1 autoantibodies in approximately 20% of patients with RA was confirmed and extended in larger panels of sera, and the finding of anti-eEF la1 shown to be relatively specific for RA. In contrast autoantibodies to the activation-induced negative regulator of T cells, CTLA-4 were not found in contrast to a previous report. The relevance of these findings for the use of antibodies in the diagnosis and prediction of disease characteristics in RA are discussed.
44
Abdel-Nour, A. N. "Cell mediated immunity in rheumatoid arthritis." Thesis, University of Bristol, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375007.
Full text
45
Côrte, Ana Filipa Terleira Camacho da. "Cervical spine instability in rheumatoid arthritis." Master's thesis, Faculdade de Medicina da Universidade do Porto, 2010. http://hdl.handle.net/10216/61051.
Full text
46
Adams, Joanna Elizabeth. "Hand function in early rheumatoid arthritis." Thesis, University of Southampton, 2006. https://eprints.soton.ac.uk/368402/.
Full textAbstract:
This thesis is about what people can do with their hands in the early stages of rheumatoid arthritis (RA). The wrist and hand are affected early in RA. Wrist and hand joint swelling, pain and deformity are all likely to contribute to the functional performance of the hand. Static splinting alongside joint protection education and active exercise is one of the most common conservative intervention strategies used by therapists. Splinting attempts to reduce local inflammation and pain, correctly position joints, minimise the occurrence or progression of deformity and maintain hand function. This thesis reviews the impact that RA can have on the hands and upper limb, examines what factors may influence function and compares the outcome measures that are used to measure this. A clinical effectiveness randomised controlled trial, examining the effectiveness of static hand splinting in early RA is described. A total of one hundred and sixteen patients with early RA were recruited onto the main trial and randomly allocated to either a splint or non-splint group. Assessments were carried out at baseline, six and 12- months. There was insufficient evidence from the results of this 12 month randomised controlled trial to suggest that using static splinting alongside standardised occupational therapy intervention was any more effective than standardised occupational therapy intervention alone in the maintenance of hand functional ability. However, when male and female participants were analysed separately young male participants could potentially experience clinically significant deleterious effects when issued with static resting splints.
47
Olinyk, O. Yu. "Metabolic syndrome in rheumatoid arthritis patients." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18595.
Full text
48
Germond, Sean Alan. "Rheumatoid arthritis : a cognitive-behavioural intervention." Master's thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/13551.
Full textAbstract:
Bibliography: leaves 190-206.This study investigated both the mediating role of psychological adjustment in determining pain experience, disease · status, and immune function in Rheumatoid Arthritis (RA), and the value of cognitive-behavioural intervention in improving the overall health status of such patients. Two related hypotheses were tested in a matched-random assigned two-groups design, with pre-, mid-, and post-intervention assessment. Fourteen (N = 14) female RA outpatients, selected along established inclusion criteria, were allocated to either treatment (n=8) or control (n=6) groups after being matched on date of disease onset and ratings, of coping efficacy. The treatment group received an eight week Stress Inoculation and Pain Management Training programme (sixteen 2-hour sessions) based on the conceptual approach of Meichenbaum (1985) and adopted from a program by O'Leary, Shoor, Lorig and Holman (1988). The program included educational material, instruction in palliative and cognitive pain management strategies and the application thereof in daily living, goal setting to improve activity function, and group discussion. The program was designed to nurture and develop existing coping skills, and to impart new strategies to cope with daily stress and pain. Pre-intervention correlational analyses tested the extent to which mood disturbance, self-perceptions of coping efficacy, health locus of control and stressful life experience were related to intensity and quality of pain, disease activity, functional status and lymphocyte proliferation rate. Intra- and inter-group analyses were conducted to determine treatment effects in terms of change scores .on the dependent measures, and case studies were conducted to evaluate individual response both to disease and cognitive-behavioural intervention.
49
Prahalad, Sampath. "Juvenile Rheumatoid Arthritis and Familial Autoimmunity." University of Cincinnati / OhioLINK, 2001. http://rave.ohiolink.edu/etdc/view?acc_num=ucin991251421.
Full text
50
Meltzer, Janet R. "Psychological adjustment in juvenile rheumatoid arthritis /." The Ohio State University, 1987. http://rave.ohiolink.edu/etdc/view?acc_num=osu148758564557603.
Full text